AURA BIOSCIENCES INC's ticker is and the CUSIP is 05153U107. A total of 74 filers reported holding AURA BIOSCIENCES INC in Q2 2024. The put-call ratio across all filers is 2.25 and the average weighting 0.1%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $18,243,928 | +403.6% | 1,163,123 | +296.5% | 6.09% | +436.0% |
Q2 2023 | $3,622,663 | +33.1% | 293,333 | 0.0% | 1.14% | +3.5% |
Q1 2023 | $2,722,130 | -11.6% | 293,333 | 0.0% | 1.10% | -4.8% |
Q4 2022 | $3,079,997 | -19.1% | 293,333 | +39.7% | 1.15% | -16.4% |
Q3 2022 | $3,805,000 | +27.9% | 210,000 | 0.0% | 1.38% | +22.3% |
Q2 2022 | $2,976,000 | -35.6% | 210,000 | 0.0% | 1.13% | -20.3% |
Q1 2022 | $4,620,000 | – | 210,000 | – | 1.42% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Medicxi Ventures Management (Jersey) Ltd | 3,039,892 | $22,981,584 | 6.86% |
Decheng Capital LLC | 515,555 | $3,897,596 | 1.19% |
Eventide Asset Management | 5,802,682 | $43,868,276 | 0.75% |
Nantahala Capital Management | 1,270,035 | $9,601,465 | 0.56% |
Matrix Capital Management Company, LP | 6,922,870 | $52,336,897 | 0.40% |
Long Focus Capital Management, LLC | 1,057,188 | $7,992,341 | 0.31% |
ADAR1 Capital Management, LLC | 203,237 | $1,536,472 | 0.29% |
LEVIN CAPITAL STRATEGIES, L.P. | 327,466 | $2,475,643 | 0.26% |
TBH Global Asset Management, LLC | 60,322 | $456,037 | 0.10% |
Corton Capital Inc. | 25,184 | $190,391 | 0.10% |